CHINET 2009 surveillance of antibiotic resistance in A. baumannii isolates in China

Chinese Journal of Infection and Chemotherapy

Volumn 10, Issue 6, 2010, Pages 441-446

  Zhang, Xiaojiang ^a   Xu, Yingchun ^a   Yu, Yunsong ^a   Yang, Qing ^a   Wang, Fu ^a   Zhu, Demei ^a   Ni, Yuxing ^a   Sun, Jingyong ^a   Sun, Ziyong ^a   Jian, Cui ^a   Hu, Yunjian ^a   Al, Xiaoman ^a   Zhang, Hong ^a   Li, Wanhua ^a   Jia, Bei ^a   Huang, Wenxiang ^a   Wang, Chuanqing ^a   Wang, Aimin ^a   Wei, Lianhua ^a   Wu, Ling ^a   Zhuo, Chao ^a   Su, Danhong ^a   Zhang, Zhaoxia ^a   Ji, Ping ^a   Xu, Yuanhong ^a   Xiong, Zizhong ^a   Shen, Jilu ^a   Shan, Bin ^a   Du, Yan ^a   more..

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Acinetobacter baumannii; Antibiotic resistance surveillance; Antimicrobial agent

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHINA; DRUG SURVEILLANCE PROGRAM; GENERAL HOSPITAL; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PEDIATRIC HOSPITAL;

EID: 78649978983     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Clinical and Laboratory Standards Institute(CLSI). Performance standards for Antimicrobial susceptibility testing [S]. M100-19, 2009.
2. Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004[J]. J Clin microbial, 2007, 45(10), 3352-3359.
3. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med, 2008, 358(12) ,1271-1281.
4. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii : no longer a controversial issue [J]. Crit Care, 2007, 11 (3): 134.
5. Perez F, Hujer AM, Hujer BK, et al. Global challenge of multidrug-resistant Acinetobacter baumannii [J]. Antimicrob Agents Chemother, 2007, 51(10) :3471-3484.
6. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii : emergence of successful pathogen [J]. Clin Microbiol Rev, 2008, 21(3):538-582.
7. Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistent Acinetobacter spp. from Chinese hospital[J]. Antimicrob Agents Chemother, 2007, 51(11); 4022-4028.
8. Zhou H, Yang Q, Yu YS, et al. Clonal spread of imipenemresistant Acinetobacter baumannii among different cities of China[J]. J Clin Microbiol, 2007, 45(12): 4054-4057.
9. Beceiro A, Lopez-Rojas R, Dominguze-Herrera J, et al. In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2009, 53(10), 4298-4304.
10. Moland ES, Craft DW, Hong SG, et al. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy[J]. Antimicrob Agents Chemother, 2008, 52(8): 2940-2942.